Navigation Links
LifeCare Holdings, Inc. Announces Year-end Results
Date:3/28/2008

the CMS regulatory changes and the increase in expenses discussed previously. As of December 31, 2007, we believe we were in compliance with all covenants contained in our senior secured credit facility, as amended.

Liquidity and Capital Resources

At December 31, 2007, our outstanding indebtedness consisted of $147.0 million aggregate principal amount of senior subordinated notes due 2013, and a $249.3 million term loan facility that matures in 2012.

The senior secured credit facility requires us to comply on a quarterly basis with certain financial covenants, including an interest coverage ratio test and a maximum leverage ratio test, which will become more restrictive over time. In addition, the senior secured credit facility includes various negative covenants, including limitations on indebtedness, liens, investments, permitted businesses, restricted payments, transactions with affiliates and other matters, as well as certain customary representations and warranties, affirmative covenants and events of default including payment defaults.

The interest rates per annum applicable to loans, other than swingline loans, under our senior secured credit facility, as amended are, at our option, equal to either an alternate base rate or an adjusted LIBOR rate for a one-, two-, three- or six-month interest period, or a nine- or twelve-month period if available, in each case, plus an applicable margin. The applicable margins on the loans, as amended, as of December 31, 2007 are (1) 3.25% for alternate base rate revolving loans, (2) 4.25% for adjusted LIBOR revolving loans, (3) 3.25% for alternate base rate term loans, and (4) 4.25% for adjusted LIBOR term loans. These margins are subject to reduction based upon the ratio of our total indebtedness to our consolidated adjusted EBITDA (as defined in the credit agreement governing our senior secured credit facility, as amended). At December 31, 2007, the interest rate applicable to the $249.9 millio
'/>"/>

SOURCE LifeCare Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. LifeCare Hospitals of Wisconsin Unveils Center for Advanced Wound Healing
2. LifeCare Holdings, Inc. Announces Third Quarter Results
3. Batesville Holdings, Inc., Appoints Doug Wilson Senior Vice President Human Resources
4. Previously Disclosed Changes in Board Composition of NightHawk Radiology Holdings, Inc. Prompt Notice of Noncompliance from the Nasdaq Global Market
5. Solera Holdings, Inc. Appoints Jason Brady as General Counsel
6. Duane Reade Holdings, Inc. to Report Fourth Quarter and Full Year 2007 Financial Results
7. Whitemark Homes Signs Letter of Intent to Acquire Metiscan Holdings, Inc.
8. Vallon Holdings, LLC Launches New Subsidiary Focused on Contract Resources for the Minneapolis-St. Paul Life Science Industry
9. NightHawk Radiology Holdings, Inc. Announces Board Member Departure
10. NightHawk Radiology Holdings, Inc. to Speak at the Cowen and Company 28th Annual Health Care Conference on March 18, 2008
11. Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...ll Webcast Monday, May 12, 08:30 a.m. EDT at ...CARLSBAD, Calif., May 12 /PRNewswire-FirstCall/ --... announced its financial results,for the quarter e...ter with,a pro forma net operating loss (NOL) of $...d to stock options, compared to a pro forma NOL,of...
(Date:5/12/2008)...RNewswire-FirstCall/ -- InfuSystem Holdings, Inc.,...ing provider of,ambulatory infusion pumps and asso...l results and provided a business update for the f...xecutive officer, commented, "We are pleased,with ...s as a stand-alone,public company, and have alread...
(Date:5/12/2008)... Nail Fungus and the Dreaded Summer Yeast Infectio...the pleasures of summer,abound, warm weather also ...en,t prepared for., Feel your best with these hea...ome elusive summertime pitfalls., From The Top --...ter,just one hour of exposure, hair begins sheddin...
(Date:5/11/2008)...1 /PRNewswire/ -- As the global community observes...ost deadly cyclone of all,time and the associated ...,for cyclone victims, the Alumni Myanmar Institute...ve-and more importantly, successful-in initiating,...r where 100,000 people,are assumed dead. AMIMA has...
Breaking Medicine News(10 mins):Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 2Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 3Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 4Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 5Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 6Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 7Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 8Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 9Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 10Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 11Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 12Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 13Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 14Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 2Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 3Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 4Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 5Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 6Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 7Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 8Health News:InfuSystem Holdings Provides Business Update and Comments on First Quarter 2008 Financial Results 9Health News:A Woman's Summertime Guide to Healthy Living From Head-to-Toe 2Health News:A Woman's Summertime Guide to Healthy Living From Head-to-Toe 3Health News:Alumni Myanmar Institutes of Medicine Association (AMIMA) Races Time to Help Cyclone Victims 2
...cted on petrochemical workers health and their ret...arly have nearly double the death rate of those wh...pproves the existing misconception that people who...er and happier lives as a consequence. Men were f...
...ly associated with good health and vitality. Howev...the body to manufacture vitamin D. //It doesn't ta... use certainly far less than it takes to get a su... better understand the complex motivations involve...
...in is being hailed as a new 'wonder drug' after it...cancer patients. New results of the trials show th...or the cancer, something that has never happened s...h tracked 5,000 patients in 39 countries, research...
...urvey conducted by Synovate India and sponsored by...gh Indians use high quality toothbrush and the lat...l of oral hygiene awareness was surprisingly low. ...tted that they have never been to a dentist in the...
Other Medicine News:
(Date:5/8/2008)...ovement in ADHD symptoms in adults, WASHINGTON, M...,Nasdaq: SHPGY), the global specialty biopharmace...hase III pivotal study in which VYVANSE,demonstrat...yperactivity,Disorder (ADHD) symptoms in adults an... with ADHD often find it challenging to focus and ...
(Date:5/8/2008)...FirstCall/ -- Siemens Healthcare and,Laboratory Co...y announced,that they have entered a non-exclusive...evelop new clinical diagnostic tests in the areas ...logy and diabetes. Under the,agreement, initial di...could make the biggest impact to patient care., (...
(Date:5/8/2008)...eeting of the American Pain Society ...wswire/ -- Patients treated with lacosamide,demons...thic pain (DNP),compared to placebo-treated patie...l meeting of the American Pain Society (APS) in Ta...trial of a diabetic neuropathic,pain treatment pro...
(Date:5/8/2008)...-FirstCall/ -- AstraZeneca (NYSE:,AZN) today annou...lication,(sNDA) to the U.S. Food and Drug Administ...ate) Extended-Release Tablets to seek approval for...D), including maintenance of,antianxiety effect. I...n,atypical antipsychotic medicine in GAD. The subm...
Breaking Medicine Technology:Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 2Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 3Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 4Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists 5Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 2Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 3Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 4New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 2New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 3New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 4AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 2AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 3AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 4AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 5AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 6AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 7AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines 8McMaster test detects the most prevalent respiratory viruses 10289 1McMaster test detects the most prevalent respiratory viruses 10289 2Millennium Biotechnologies Group Reports 40 25 Sales Increase for Resurgex Product Line in Greek Market 2785 1Millennium Biotechnologies Group Reports 40 25 Sales Increase for Resurgex Product Line in Greek Market 2785 2Liquent Insight Publisher 3 6 Delivers Advanced Submission Capabilities 10286 1Liquent Insight Publisher 3 6 Delivers Advanced Submission Capabilities 10286 2Drop of Flu Vaccine Under Tongue Bars Infection 10284 1Drop of Flu Vaccine Under Tongue Bars Infection 10284 2
Facilitates one-lung ventilation when using dual lumen endobronchial tubes.
...lbroncho is a double lumen tube made of silicone r...p., ,Due to the characteristics of silicone rubbe...ient at insertion. Furthermore, the tube will not ...ble for long term surgery., ,Silbronco is also es...
Used for endobronchial blockade of the left or right lung for procedures which require one-lung ventilation. The set consists of an endobronchial blocker catheter and an Arndt Multiport Airway Adapte
...e Mini-Trach® II kit includes a guarded scalpe...ISO connector, and a 10fr suction catheter., ,The...ponents needed to perform a cricothyrotomy., ,Wit... (4.0 mm I.D.) is inserted into the trachea throug...
Medicine Products: